308 related articles for article (PubMed ID: 15584968)
1. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
[TBL] [Abstract][Full Text] [Related]
2. Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis.
Snow AD; Kisilevsky R; Stephens C; Anastassiades T
Lab Invest; 1987 Jun; 56(6):665-75. PubMed ID: 3599910
[TBL] [Abstract][Full Text] [Related]
3. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink.
Wien TN; Sørby R; Omtvedt LA; Landsverk T; Husby G
Scand J Immunol; 2004 Dec; 60(6):600-8. PubMed ID: 15584971
[TBL] [Abstract][Full Text] [Related]
5. Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
Stenstad T; Magnus JH; Husby G
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):663-70. PubMed ID: 7980430
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
Brandwein SR; Sipe JD; Skinner M; Cohen AS
J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
[TBL] [Abstract][Full Text] [Related]
7. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
Ailles L; Kisilevsky R; Young ID
Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
[TBL] [Abstract][Full Text] [Related]
8. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
Gonnerman WA; Kandel R; Cathcart ES
Lab Invest; 1996 Jan; 74(1):259-64. PubMed ID: 8569190
[TBL] [Abstract][Full Text] [Related]
9. Co-deposition of basement membrane components during the induction of murine splenic AA amyloid.
Lyon AW; Narindrasorasak S; Young ID; Anastassiades T; Couchman JR; McCarthy KJ; Kisilevsky R
Lab Invest; 1991 Jun; 64(6):785-90. PubMed ID: 2046330
[TBL] [Abstract][Full Text] [Related]
10. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
Snow AD; Kisilevsky R
Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
[TBL] [Abstract][Full Text] [Related]
11. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
Brandwein SR; Sipe JD; Skinner M; Cohen AS
Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
[TBL] [Abstract][Full Text] [Related]
12. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study.
Inoue S; Hultin PG; Szarek WA; Kisilevsky R
Lab Invest; 1996 Jun; 74(6):1081-90. PubMed ID: 8667612
[TBL] [Abstract][Full Text] [Related]
13. Presence and role of glycosaminoglycans in amyloidosis.
Linker A; Carney HC
Lab Invest; 1987 Sep; 57(3):297-305. PubMed ID: 3626519
[TBL] [Abstract][Full Text] [Related]
14. In vivo analysis of murine serum sulfate metabolism and splenic glycosaminoglycan biosynthesis during acute inflammation and amyloidosis.
Lyon AW; Anastassiades T; Kisilevsky R
J Rheumatol; 1993 Jul; 20(7):1108-13. PubMed ID: 8371201
[TBL] [Abstract][Full Text] [Related]
15. Further characterization of amyloid-enhancing factor.
Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
[TBL] [Abstract][Full Text] [Related]
16. Brefeldin A inhibits experimentally induced AA amyloidosis.
Stenstad T; Husby G
J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
[TBL] [Abstract][Full Text] [Related]
17. Mouse senile amyloidosis. ASSAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis.
Higuchi K; Naiki H; Kitagawa K; Hosokawa M; Takeda T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(4):231-8. PubMed ID: 1681611
[TBL] [Abstract][Full Text] [Related]
18. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis.
Snow AD; Bramson R; Mar H; Wight TN; Kisilevsky R
J Histochem Cytochem; 1991 Oct; 39(10):1321-30. PubMed ID: 1940305
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin: its potential significance in murine AA amyloidogenesis.
Chronopoulos S; Lembo P; Alizadeh-Khiavi K; Ali-Khan Z
J Pathol; 1992 Jun; 167(2):249-59. PubMed ID: 1321903
[TBL] [Abstract][Full Text] [Related]
20. The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.
Kawahara E; Shiroo M; Nakanishi I; Migita S
Am J Pathol; 1989 Jun; 134(6):1305-14. PubMed ID: 2757120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
